Review



cdp323 (biogen/ucb  (Biogen Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Biogen Inc cdp323 (biogen/ucb
    Cdp323 (Biogen/Ucb, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cdp323 (biogen/ucb/product/Biogen Inc
    Average 90 stars, based on 1 article reviews
    cdp323 (biogen/ucb - by Bioz Stars, 2026-02
    90/100 stars

    Images



    Similar Products

    zaurategrast cdp323  (MedChemExpress)
    93
    MedChemExpress zaurategrast cdp323
    Zaurategrast Cdp323, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/zaurategrast cdp323/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    zaurategrast cdp323 - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier
    cdp323  (MedChemExpress)
    91
    MedChemExpress cdp323
    Cdp323, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cdp323/product/MedChemExpress
    Average 91 stars, based on 1 article reviews
    cdp323 - by Bioz Stars, 2026-02
    91/100 stars
    		  Buy from Supplier
    cdp323 (biogen/ucb  (Biogen Inc)
    90
    Biogen Inc cdp323 (biogen/ucb
    Cdp323 (Biogen/Ucb, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cdp323 (biogen/ucb/product/Biogen Inc
    Average 90 stars, based on 1 article reviews
    cdp323 (biogen/ucb - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    cdp323 (phase ii)  (Biogen Inc)
    90
    Biogen Inc cdp323 (phase ii)
    Cdp323 (Phase Ii), supplied by Biogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cdp323 (phase ii)/product/Biogen Inc
    Average 90 stars, based on 1 article reviews
    cdp323 (phase ii) - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    cdp323  (UCB SA Inc)
    90
    UCB SA Inc cdp323
    Cdp323, supplied by UCB SA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cdp323/product/UCB SA Inc
    Average 90 stars, based on 1 article reviews
    cdp323 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    cdp323  (Certara L.P)
    90
    Certara L.P cdp323
    Cdp323, supplied by Certara L.P, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cdp323/product/Certara L.P
    Average 90 stars, based on 1 article reviews
    cdp323 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    cdp323  (Biogen Inc)
    90
    Biogen Inc cdp323
    Percentage change from baseline in absolute lymphocyte counts at day 28 following treatment with <t> CDP323 </t> for 28 days (per protocol population).
    Cdp323, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cdp323/product/Biogen Inc
    Average 90 stars, based on 1 article reviews
    cdp323 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Percentage change from baseline in absolute lymphocyte counts at day 28 following treatment with CDP323 for 28 days (per protocol population).

    Journal: PLoS ONE

    Article Title: Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study

    doi: 10.1371/journal.pone.0058438

    Figure Lengend Snippet: Percentage change from baseline in absolute lymphocyte counts at day 28 following treatment with CDP323 for 28 days (per protocol population).

    Article Snippet: Small-molecule α 4 antagonists such as CDP323 (UCB Pharma, Brussels, Belgium, and Biogen Idec, Weston, MA, USA), a phenylalanine enamide mixed α 4 antagonist , have been considered potential alternatives to therapeutic antibodies because of their increased selectivity for specific α 4 -containing integrin complexes, their inhibition of different affinity states, and the increased patient convenience of oral dosing – .

    Techniques: